Literature DB >> 24439594

Patient and parental scar assessment after single incision versus standard 3-port laparoscopic appendectomy: long-term follow-up from a prospective randomized trial.

Alessandra C Gasior1, E Marty Knott1, George W Holcomb1, Daniel J Ostlie1, Shawn D St Peter2.   

Abstract

BACKGROUND: Single site laparoscopy for appendectomy is a technique with several case series suggesting a cosmetic advantage, but without prospective comparative data. We conducted a prospective, randomized trial comparing single site laparoscopic appendectomy to the standard 3-port approach, including scar assessment at early and long-term follow-up.
METHODS: Enrolled patients over 12years old and parents of patients less than 12years old were asked to complete the validated Patient Scar Assessment Questionnaire (PSAQ) at early follow-up around 6weeks and by phone after 18months. The PSAQ consists of 4 scored subscales: Appearance, Consciousness, Appearance Satisfaction, and Symptom Satisfaction. Each subscale has a set of questions with a 4-point categorical response (1=most favorable, 4=least favorable). The sum of the scores quantifies each subscale.
RESULTS: Early questionnaires were obtained from 98 3-port and 100 single-site patients with the single-site approach producing superior overall scar assessment (P=0.003). By telephone follow-up, questionnaires were completed by 49 3-port and 56 single-site patients at a median of 25 (18-32) months. In this longer-term follow-up, overall scar assessment was not significantly different between groups (P=0.06).
CONCLUSION: Patients or parents express superior scar assessment with the single site approach at early follow-up, but this difference disappears in the long-term.
© 2014.

Entities:  

Keywords:  Appendectomy; Cosmetic; Laparoscopy; Pediatrics; Single-incision

Mesh:

Year:  2013        PMID: 24439594     DOI: 10.1016/j.jpedsurg.2013.09.041

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  7 in total

Review 1.  Pediatric appendicitis: state of the art review.

Authors:  Rebecca M Rentea; Shawn D St Peter; Charles L Snyder
Journal:  Pediatr Surg Int       Date:  2016-10-14       Impact factor: 1.827

2.  Single-incision laparoscopic surgery (SILS) for children with Crohn's disease.

Authors:  Justin T Huntington; Laura A Boomer; Victoria K Pepper; Karen A Diefenbach; Jennifer L Dotson; Benedict C Nwomeh
Journal:  Pediatr Surg Int       Date:  2016-02-13       Impact factor: 1.827

3.  Single-site laparoscopic appendectomy in children using conventional instruments: a prospective, randomized, control trial.

Authors:  Kai Wu; Liucheng Yang; Aiguo Wu; Jianjun Wang; Shuai Xu; Haijun Zhao; Zonghai Huang
Journal:  Pediatr Surg Int       Date:  2014-11-09       Impact factor: 1.827

Review 4.  The laparoscopic approach for repair of indirect inguinal hernias in infants and children.

Authors:  David Juang; Jason D Fraser; George W Holcomb
Journal:  Transl Pediatr       Date:  2016-10

5.  Postoperative narcotic utilization in single incision laparoscopic-assisted extracorporeal appendectomy (SILEA): a single-institution retrospective review.

Authors:  Allen Zhong; Celia Short; Andrew Sundin; Charlotte Austin; Leland Gao; Emiliano Tabarsi; Stephanie Chen; Kasper Wang; Juan Carlos Pelayo
Journal:  Pediatr Surg Int       Date:  2022-09-22       Impact factor: 2.003

Review 6.  Outcome reporting in randomised controlled trials and meta-analyses of appendicitis treatments in children: a systematic review.

Authors:  Nigel J Hall; Mufiza Z Kapadia; Simon Eaton; Winnie W Y Chan; Cheri Nickel; Agostino Pierro; Martin Offringa
Journal:  Trials       Date:  2015-06-17       Impact factor: 2.279

7.  Single plus one-port robotic surgery using the da Vinci Single-Site Platform versus conventional multi-port laparoscopic surgery for left-sided colon cancer.

Authors:  Sung Uk Bae; Woon Kyung Jegon; Seong Kyu Baek
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2022-01-18       Impact factor: 1.195

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.